Thiazolidinediones, alpha-glucosidase inhibitors, Meglitinides, sulfonylureas, and hepatocellular carcinoma risk: a meta-analysis

This study evaluated associations between sulfonylureas, thiazolidinediones, meglitinides and alpha-glucosidase inhibitors, and incident HCC risk.

Source: Metabolism - Clinical and Experimental - April 20, 2021 Category: Biomedical Science Authors: Ashwini Arvind, Zoe N. Memel, Lisa L. Philpotts, Hui Zheng, Kathleen E. Corey, Tracey G. Simon Source Type: research